Dysentery became curable when sulfonamide antibiotics were introduced in the early 1940s, followed by the global adoption of oral rehydration therapy in the late 1960s.
Early attempts and the rise of antibiotics
Before the 20th century, treatment options were limited to astringents, opiates, and herbal purges. Mortality rates stayed high because the underlying cause—massive fluid loss—was not addressed.
In 1940, sulfonamides became the first systemic antibiotics capable of suppressing bacterial growth in the gut. Their use during World War II dramatically lowered death rates among soldiers infected with Shigella.
Oral rehydration therapy: a game changer
In the late 1960s, researchers at the SEATO Cholera Research Laboratory discovered that the sodium‑glucose cotransporter in the small intestine remains functional during severe diarrhea. By mixing glucose, sodium chloride, potassium chloride, and citrate in clean water, patients could absorb fluids and electrolytes orally.
ORT proved to be inexpensive, easy to administer, and highly effective. During the 1971 Bangladesh Liberation War, mortality fell from over 50% to below 5% when ORT was widely used.
Modern treatment strategy
Today, successful management relies on two pillars: targeted antibiotics for bacterial dysentery and ORT for immediate hydration. Amoebic dysentery requires specific anti‑amoebic drugs such as metronidazole.
In regions where clean water is scarce, ORT remains the cornerstone of care. Zinc supplementation in children shortens illness duration and supports intestinal repair.
Challenges and the future
Antibiotic resistance has emerged as a growing problem. Shigella strains now frequently resist first‑line drugs, making susceptibility testing essential.
Continued research focuses on vaccines, improved diagnostics, and sustainable water‑sanitation solutions to reduce dysentery incidence worldwide.